These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26040913)

  • 1. Zooming into the binding groove of HLA molecules: which positions and which substitutions change peptide binding most?
    van Deutekom HW; Keşmir C
    Immunogenetics; 2015 Aug; 67(8):425-36. PubMed ID: 26040913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320.
    Zeliszewski D; Golvano JJ; Gaudebout P; Dorval I; Freidel C; Gebuhrer L; Betuel H; Borras-Cuesta F; Sterkers G
    J Immunol; 1993 Dec; 151(11):6237-47. PubMed ID: 7504016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide: molecular dynamics simulations of HLA-A*0217.
    Toh H; Savoie CJ; Kamikawaji N; Muta S; Sasazuki T; Kuhara S
    Biopolymers; 2000 Oct; 54(5):318-27. PubMed ID: 10935972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of amino acid substitutions in the beta-sheet floor and alpha-2 helix of HLA-A2 on recognition by alloreactive viral peptide-specific cytotoxic T lymphocytes.
    Mattson DH; Shimojo N; Cowan EP; Baskin JJ; Turner RV; Shvetsky BD; Coligan JE; Maloy WL; Biddison WE
    J Immunol; 1989 Aug; 143(4):1101-7. PubMed ID: 2473117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic family.
    Bade-Döding C; Theodossis A; Gras S; Kjer-Nielsen L; Eiz-Vesper B; Seltsam A; Huyton T; Rossjohn J; McCluskey J; Blasczyk R
    Haematologica; 2011 Jan; 96(1):110-8. PubMed ID: 20934997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single amino acid substitution in HLA-A2 can alter the selection of the cytotoxic T lymphocyte repertoire that responds to influenza virus matrix peptide 55-73.
    Shimojo N; Cowan EP; Engelhard VH; Maloy WL; Coligan JE; Biddison WE
    J Immunol; 1989 Jul; 143(2):558-64. PubMed ID: 2472444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Analysis of the Naturally Processed Peptide Repertoire: Differences between HLA-A and B in the Immunopeptidome.
    Schellens IM; Hoof I; Meiring HD; Spijkers SN; Poelen MC; van Gaans-van den Brink JA; van der Poel K; Costa AI; van Els CA; van Baarle D; Kesmir C
    PLoS One; 2015; 10(9):e0136417. PubMed ID: 26375851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular transport of class I HLA molecules is affected by polymorphic residues in the binding groove.
    Salter RD
    Immunogenetics; 1994; 39(4):266-71. PubMed ID: 8119733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A roadmap for HLA-A, HLA-B, and HLA-C peptide binding specificities.
    Chelvanayagam G
    Immunogenetics; 1996; 45(1):15-26. PubMed ID: 8881033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of two novel alleles HLA-B*3569 and -B*4450 and confirmation of HLA-A*2631 in the Brazilian population.
    Abdeen H; McErlean C; Moraes ME; Romero M; Marques SB; Goncales AC; Guariento EG; Middleton D
    Tissue Antigens; 2007 Mar; 69(3):273-6. PubMed ID: 17493154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mismatches outside exons 2 and 3 do not alter the peptide motif of the allele group B*44:02P.
    Bade-Doeding C; Cano P; Huyton T; Badrinath S; Eiz-Vesper B; Hiller O; Blasczyk R
    Hum Immunol; 2011 Nov; 72(11):1039-44. PubMed ID: 21872626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function and polymorphism of human leukocyte antigen-A,B,C molecules.
    Parham P
    Am J Med; 1988 Dec; 85(6A):2-5. PubMed ID: 2462346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A polymorphic pocket at the P10 position contributes to peptide binding specificity in class II MHC proteins.
    Zavala-Ruiz Z; Strug I; Anderson MW; Gorski J; Stern LJ
    Chem Biol; 2004 Oct; 11(10):1395-402. PubMed ID: 15489166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Position 45 influences the peptide binding motif of HLA-B*44:08.
    Badrinath S; Huyton T; Schumacher H; Blasczyk R; Bade-Doeding C
    Immunogenetics; 2012 Mar; 64(3):245-9. PubMed ID: 22009320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of HLA-B α-3 domain amino acid position 194 in HIV disease progression.
    Grifoni A; Montesano C; Palma P; Salerno A; Colizzi V; Amicosante M
    Mol Immunol; 2013 Apr; 53(4):410-3. PubMed ID: 23103378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping and ranking of potential cytotoxic T epitopes in the p53 protein: effect of mutations and polymorphism on peptide binding to purified and refolded HLA molecules.
    Gnjatic S; Bressac-de Paillerets B; Guillet JG; Choppin J
    Eur J Immunol; 1995 Jun; 25(6):1638-42. PubMed ID: 7542198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The peptide length specificity of some HLA class I alleles is very broad and includes peptides of up to 25 amino acids in length.
    Bell MJ; Burrows JM; Brennan R; Miles JJ; Tellam J; McCluskey J; Rossjohn J; Khanna R; Burrows SR
    Mol Immunol; 2009 May; 46(8-9):1911-7. PubMed ID: 19157553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression.
    Stewart-Jones GB; Gillespie G; Overton IM; Kaul R; Roche P; McMichael AJ; Rowland-Jones S; Jones EY
    J Immunol; 2005 Aug; 175(4):2459-68. PubMed ID: 16081817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide binding specificities of HLA-B*5701 and B*5801.
    Zhang Y; Mei H; Wang Q; Xie J; Lv J; Pan X; Tan W
    Sci China Life Sci; 2012 Sep; 55(9):818-25. PubMed ID: 23015131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A panel of unique HLA-A2 mutant molecules define epitopes recognized by HLA-A2-specific antibodies and cytotoxic T lymphocytes.
    Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1989 Mar; 142(6):2097-104. PubMed ID: 2466083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.